Abstract

Adecoagro SA will report quarterly results on August 11, 2026 Post-Mkt; this preview distills market forecasts for revenue, profitability, and EPS, reviews last quarter’s performance and segment trends, and synthesizes fresh institutional views to frame near‑term catalysts and risks.

Market Forecast

The market expects Adecoagro SA to post revenue of 602.01 million US dollars for the current quarter, an estimated year-over-year increase of 45.85%, with EBIT forecast at 87.46 million US dollars (up 55.51% YoY) and EPS at 0.20 (down 23.46% YoY). Consensus points to continued recovery in margins, with focus on mix and operating leverage; if disclosed, investors will watch gross margin and net margin alongside adjusted EPS progression. Highlights center on stabilization in core sugar, ethanol and agriculture-linked processing activities, with expectations of higher throughput and improved pricing; the most promising stream is the manufactured products and services franchise, projected to lead growth, while agriculture production and biological assets should provide supplementary volume upside.

Last Quarter Review

In the previous quarter, Adecoagro SA reported revenue of 398.68 million US dollars, a gross profit margin of 20.47%, GAAP net profit attributable to the parent company of 40.14 million US dollars, a net profit margin of 10.07%, and adjusted EPS of -0.24; revenue grew 22.48% year over year while EPS declined 84.62% year over year. A key highlight was a sharp quarter-on-quarter rebound in GAAP profitability, with net profit up 370.30% as operations normalized and mix improved. By segment, manufactured products and services generated 359.63 million US dollars (approximately 90.21% of revenue), while agriculture production and biological assets delivered 39.05 million US dollars (about 9.79%); the emphasis fell on stronger processing volumes and commercial execution compared with a softer primary production contribution.

Current Quarter Outlook (with major analytical insights)

Main business: Manufactured products and services

Manufactured products and services is the company’s revenue engine, contributing about nine-tenths of recent quarterly sales. The current forecast implies robust top-line expansion against last year, driven by throughput recovery in sugar and ethanol operations and supportive pricing in downstream processed goods. Margin sensitivity this quarter will hinge on feedstock costs and hedging; with gross margin last quarter at 20.47%, even incremental efficiency gains in crushing and logistics could translate to meaningful EBIT uplift given the 87.46 million US dollars EBIT estimate. Operating leverage should be visible as fixed cost absorption improves with higher volumes, but any adverse movement in energy or transportation costs could temper gains.

Most promising business: Processing-led growth with mix tailwinds

The manufactured products portfolio is positioned to deliver the fastest growth, benefitting from higher utilization and pricing discipline. The revenue estimate of 602.01 million US dollars implies broad-based expansion, and given segment concentration, most of this increase is expected to accrue to processing. We expect YoY growth to be led by better mix (higher-value refined outputs) and more favorable export realizations where applicable. If currency dynamics remain supportive and hedging strategies limit volatility, this segment could outperform the revenue plan and translate growth into EBIT above the current 55.51% YoY forecast. However, should commodity spreads narrow late in the quarter, the translation to bottom line may fall closer to plan.

Stock-price drivers this quarter: EPS trajectory, margins, and ag-cycle risks

With consensus EPS at 0.20, sentiment will be sensitive to whether efficiency and pricing gains offset higher input costs to stabilize EPS after last quarter’s negative print. Commentary on gross and net margins will be pivotal; investors will likely benchmark progress against last quarter’s 20.47% gross margin and 10.07% net margin, watching for signs of sustainability as volumes scale. The agriculture production and biological assets line remains a swing factor; weather, yields, and biological fair-value changes can add volatility to reported profits and EPS. A clean beat on revenue with corroborating margin expansion could re-rate expectations upward; conversely, if EPS lags despite strong sales, multiple compression risk could emerge as markets question cost control and mix quality.

Analyst Opinions

Bullish opinions dominate recent institutional commentary, with a majority expecting revenue acceleration and improving operating leverage to lift profitability even as EPS faces tougher year-over-year comps. Analysts emphasize that a 45.85% revenue increase alongside a 55.51% EBIT expansion would validate recovery in processing throughput and pricing, reinforcing confidence in manufactured products as the growth spine. Coverage notes that last quarter’s 22.48% revenue growth and a 370.30% sequential rebound in GAAP net profit provide a constructive base, and that management execution on cost discipline and hedging could unlock additional EPS upside versus the 0.20 expectation. Institutions flag sensitivity to commodity and weather volatility but frame these as manageable within the current guidance context, leaving the balance of views supportive into the print.